 |
Tendinopathy -- From Basic Science to Treatment CME DisclosuresRelease Date: January 28, 2008; Valid for credit through January 28, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| The content of this CME activity, "Tendinopathy -- From Basic Science to Treatment," was developed by the faculty.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
Soft-tissue disorders are the second most common rheumatologic condition in the United Kingdom, with 18 cases per 1000 people, and are the main reasons for consultation with a general practitioner, constituting 30% of all visits. An understanding of the mechanisms underlying tendon injury and healing will allow improved management and development of future treatments. - Tendinopathy -- From Basic Science to Treatment
Graham Riley, PhD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Identify the primary mechanism leading to tendinopathy
- Describe the prevalence of soft-tissue injury and tendinopathy in the United Kingdom
- Describe repair mechanisms after tendon injury
- List key
elements of the extracellular matrix in tendon
- Describe the evidence for the efficacy of newer treatments for tendinopathy
Authors and Disclosures |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
